Depressive episodes
Conditions
Interventions
Experimental group: 64 patients, women, and men from 18 to 70 years-old, who are on long-term benzodiazepines and antidepressants in primary care, without a psychiatric evaluation assessment in the 12
Drug
Sponsors
Universidade Federal de São Carlos
Universidade Federal de São Carlos
Eligibility
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Users of the Basic Health Unit Cidade Aracy (Sao Carlos - Sao Paulo/Brazil), who are on antidepressants; and/or benzodiazepines; without psychiatric follow-up in the 12 months prior to inclusion
Exclusion criteria
Exclusion criteria: Schizophrenia; bipolar and substance use disorders (except benzodiazepines and tobacco). A suicide attempt in the 12 months prior to inclusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Statistically significant mental health score improvement in the experimental group as compared to control group, assessed by the mental component of the 12-Item Short-Form Health Survey (SF-12) at month 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure—Adult, monthly assessed;12-Item Short-Form Health Survey mental and physical scores, monthly assessed;Number of psychotropic medicines daily prescribed, monthly assessed;Daily dose of psychotropic medication, monthly assessed;Treatment response rate, defined as an equal or greater to 50% reduction in DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure—Adult basal score, monthly assessed;Adverse Event incidence | — |
Countries
Brazil
Contacts
Public ContactUbiratan Adler
Unidade de Saúde Escola da Universidade Federal de São Carlos
Outcome results
None listed